These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 1096573
41. [New therapeutic indications for a dopamine antagonist, Piribedyl]. Schmitt H, Laubie M, Poignant JC, Krikorian A, Evrard Y, Freyria JL, Arnaud F. Sem Hop; 1978 Mar; 54(5-8):325-34. PubMed ID: 211628 [Abstract] [Full Text] [Related]
42. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Castro-Caldas A, Delwaide P, Jost W, Merello M, Williams A, Lamberti P, Aguilar M, Del Signore S, Cesaro P, Parkinson-Control Study Group. Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842 [Abstract] [Full Text] [Related]
43. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease]. Miranda M, Saéz D. Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172 [Abstract] [Full Text] [Related]
44. ['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine]. Jansen EN, van Laar T. Ned Tijdschr Geneeskd; 1990 May 05; 134(18):889-91. PubMed ID: 2345577 [No Abstract] [Full Text] [Related]
45. End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study. Simon N, Micallef J, Reynier JC, Lesourd M, Witjas T, Alicherif A, Azulay JP, Blin O. Mov Disord; 2005 Jul 05; 20(7):803-9. PubMed ID: 15726579 [Abstract] [Full Text] [Related]
46. Parkinsonism by haloperidol and piribedil. Corsini GU, Del Zompo M, Spissu A, Mangoni A, Gessa GL. Psychopharmacology (Berl); 1978 Oct 31; 59(2):139-41. PubMed ID: 103114 [Abstract] [Full Text] [Related]
54. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine. Kempster PA, Lees AJ, Crichton P, Frankel JP, Shorvon P. Mov Disord; 1989 Jan 25; 4(1):47-52. PubMed ID: 2927402 [Abstract] [Full Text] [Related]
55. [Hypertension and impotence. Which potency drug is the most appropriate here?]. Köhn FM. MMW Fortschr Med; 2002 Mar 07; 144(10):12-3. PubMed ID: 11928255 [No Abstract] [Full Text] [Related]
58. [Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results]. Oules MJ, Boscredon J. Ann Med Psychol (Paris); 1979 Nov 07; 137(9):921-5. PubMed ID: 547794 [No Abstract] [Full Text] [Related]
59. Amphetamine and piribedil in affective illness. Post RM, Jimerson DC, Silberman EK. Psychopharmacol Bull; 1980 Jan 07; 16(1):57-9. PubMed ID: 6987695 [No Abstract] [Full Text] [Related]